Acceleron Reports First Quarter 2020 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Acceleron Reports First Quarter 2020 Operating and Financial Results

Acceleron Pharma (XLRN) Misses Q1 EPS by 9c

May 11, 2020 4:25 PM EDT

Acceleron Pharma (NASDAQ: XLRN) reported Q1 EPS of ($0.95), $0.09 worse than the analyst estimate of ($0.86).

Acceleron is off to a strong start in 2020, propelled by one of the most eventful time periods in the Companys history, said Habib Dable, President and Chief Executive Officer of Acceleron. The breadth and depth of our hematology program has been on full display, owing to the publication... More